Vulva squamous cell carcinoma is a cancer that starts in the skin of the vulva, and it most often affects older adults, though it can happen earlier. Early symptoms of vulva squamous cell carcinoma can include persistent itching, pain, a sore or lump, skin color changes, or bleeding that is not part of a period. It usually develops over time rather than appearing suddenly, and treatment often involves surgery with or without radiation or chemotherapy. Not everyone will have the same experience. Vulva squamous cell carcinoma can be serious and sometimes life threatening, but outcomes are often better when it is found and treated early.
How many people live with Vulva squamous cell carcinoma?
Worldwide, about 150,000 people were living with vulvar cancer within 5 years of diagnosis (GLOBOCAN, 2022); since about 80% to 90% of vulvar cancers are the squamous cell type, this suggests roughly 120,000 to 135,000 people worldwide living with vulva squamous cell carcinoma, although that is an estimate rather than a direct count. In the United States, about 24,000 people were living with vulvar cancer within 5 years of diagnosis (GLOBOCAN, 2022), which suggests roughly 19,000 to 22,000 were living with the squamous cell type, again as an estimate rather than a direct count.
Overview
Vulva squamous cell carcinomaSymptoms
Vulva squamous cell carcinoma often causes persistent itching, burning, pain, or a sore or lump on the vulva that does not heal. Early symptoms of vulva squamous cell carcinoma can also include skin color changes, thickened skin, or bleeding.
Outlook and prognosis
The outlook for vulva squamous cell carcinoma is often good when it is found early and treated before it has spread. Recovery and long-term survival depend mainly on tumor size, lymph node involvement, and whether the cancer comes back after treatment.
Causes and risk factors
Vulva squamous cell carcinoma is linked to long-term HPV infection or chronic vulvar skin disease. Risk rises with smoking, older age, immune suppression, and prior cervical or vulvar precancer. Genetics usually play a smaller role.
Genetic influences
Genetics can matter in vulva squamous cell carcinoma, but inherited causes are uncommon. Most cases are linked more to acquired DNA changes over time, often alongside HPV infection or chronic skin conditions, than to a strong family pattern.
Diagnosis
Vulva squamous cell carcinoma is usually diagnosed after a pelvic exam finds a suspicious sore, lump, or skin change. A small tissue sample, called a biopsy, confirms it. Imaging scans may then check whether it has spread.
Treatment and drugs
Vulva squamous cell carcinoma is often treated with surgery to remove the cancer, sometimes along with nearby lymph nodes. Some people also need radiation, chemotherapy, or both. Treatment depends on the tumor size, location, and whether it has spread.
Symptoms
Changes in the vulva can be easy to brush off at first, especially if they seem like simple irritation. You might notice small changes at first, such as itching that does not go away, a sore spot, or skin that looks thicker or different in color. Vulva squamous cell carcinoma can also cause pain, burning, bleeding, or a new lump, although some people have few symptoms early on. Because the early symptoms of vulva squamous cell carcinoma can resemble common skin problems, changes that last more than a few weeks should be checked.
Itching in one area of the vulva that keeps coming back or never fully settles is common. It may feel worse at night or become distracting during walking, sitting, or exercise.
Some people feel soreness, stinging, or a burning sensation on the vulva. With vulva squamous cell carcinoma, this discomfort can happen even without touching the area or can worsen with sex, tight clothing, or long periods of sitting.
The skin may look thicker, rougher, paler, darker, redder, or more irritated than the surrounding area. In vulva squamous cell carcinoma, these changes often stay in one spot instead of clearing up like a short-lived rash.
A new raised area, firm patch, or wart-like bump can develop on the vulva. Some may find that it catches on underwear or feels tender when washing.
How people usually first notice Vulva squamous cell carcinoma?
Many people first notice vulva squamous cell carcinoma because an area of the vulva starts to feel different before it looks dramatic: itching that does not go away, burning, soreness, pain, or a spot that feels thickened, raised, or unusually tender. As vulva squamous cell carcinoma develops, some may also notice a lump, an open sore or wart-like patch, skin color changes, or light bleeding, spotting, or discharge that is not typical for them, especially after menopause. These changes are often mistaken for irritation, infection, or a skin condition at first, so if a vulvar symptom keeps coming back or lasts more than a few weeks, it is worth getting checked.
Types of Vulva squamous cell carcinoma
Vulva squamous cell carcinoma can show up in a few recognized forms, and they do not always affect daily life in the same way. Some types of vulva squamous cell carcinoma are linked to human papillomavirus, while others are more often linked to long-term skin changes of the vulva and tend to occur later in life. Symptoms don’t always look the same for everyone. Early symptoms of vulva squamous cell carcinoma may include itching, burning, pain, a sore that does not heal, or a lump or thickened patch of skin.
HPV-related
This type is often seen in younger adults and may start as a small raised, rough, or wart-like area on the vulva. It can cause itching, irritation, or spotting, though some people notice very few symptoms at first. It is commonly linked to changes in the surface skin caused by high-risk HPV.
HPV-independent
This type is more common in older adults and often develops in skin that has had long-term irritation or inflammatory change. Many living with this form notice a persistent sore, firm lump, thickened patch, or ongoing vulvar pain or itching. It may look less wart-like and more like a hard or ulcerated area.
Warty or basaloid
These are subtypes within HPV-related vulva squamous cell carcinoma and are usually grouped together because they behave in similar ways. Some may find that the area looks uneven, raised, or wart-like, with itching or tenderness during walking, washing, or sex. They are most often diagnosed under the microscope rather than by appearance alone.
Keratinizing
This is the most common subtype overall and is usually part of the HPV-independent group. It often appears as a thick, dry, scaly, or ulcerated patch that slowly enlarges over time. For many, this can mean long-standing itching followed by pain, bleeding, or discomfort that becomes harder to ignore.
Can I slow down the onset of symptoms?
Not in a reliable way: there is no proven lifestyle change or treatment that can guarantee a later start of symptoms from vulvar squamous cell carcinoma, but some steps can lower the chance of this cancer developing in the first place. The best-supported steps are not smoking, getting the HPV vaccine if you are eligible, and having ongoing care for long-lasting vulvar skin problems such as itching, white patches, sores, or other changes, because treating these early may reduce risk but does not prevent cancer for everyone. There is no routine screening test for all adults, so the most helpful medical step is to get any vulvar lump, sore, pain, bleeding, or skin change checked early; that cannot promise prevention, but it can improve the chance of finding problems sooner.
What genetics can tell you about symptoms
In vulvar squamous cell carcinoma, genetics can give doctors some clues about how the cancer developed and how it may behave, but it usually cannot predict exactly which symptoms someone will have day to day. Certain gene changes in the tumor itself, and whether the cancer is linked to human papillomavirus, can be associated with different pathways of disease and sometimes with how fast it grows, which may affect when symptoms begin or how serious they become. Still, for most people living with this cancer, symptoms are driven more by the tumor’s size, location, and stage than by inherited genetic differences.
Causes and risk factors
Most vulva squamous cell carcinoma is linked to long-term cell damage from certain types of HPV or from ongoing vulvar skin disease such as lichen sclerosus. Risk rises with older age, smoking, and a weakened immune system. Past precancer or cancer of the vulva, cervix, or vagina is one of the key risk factors for vulva squamous cell carcinoma. Inherited gene changes are not a common main cause, but family history may slightly affect risk in some people. Having risk factors does not mean you will definitely develop vulva squamous cell carcinoma.
What are the most common causes or risk factors?
The most common risk factors for vulvar squamous cell carcinoma are a long-lasting infection with certain types of HPV, a common virus spread through sexual contact, and ongoing irritation or inflammation of the vulva, especially a chronic itchy skin condition called lichen sclerosus. Risk is also higher in older age, in people who smoke, and in those with a weakened immune system, such as after an organ transplant or with HIV. This cancer is usually not strongly inherited, so family history is not a major cause for most people living with it.
Environmental and biological risk factors
Vulva squamous cell carcinoma can develop through more than one pathway, so risk is not the same for everyone. Doctors often group risks into internal (biological) and external (environmental). The main risk factors for vulva squamous cell carcinoma include persistent HPV infection, long-term vulvar skin disease, immune suppression, and older age.
Risk rises with age, especially after menopause. Many people with vulva squamous cell carcinoma are older adults, although some HPV-related cases happen earlier in life.
Long-lasting infection with high-risk HPV can cause abnormal cell changes in the vulva over time. This is one of the best-known risk factors for vulva squamous cell carcinoma.
Precancerous vulvar changes, often called VIN, raise the chance that cancer may develop if they persist or come back. Regular follow-up is important because these abnormal cells can sometimes progress to vulva squamous cell carcinoma.
This long-term inflammatory skin condition of the vulva is linked to a non-HPV pathway to cancer. Risk is higher when skin changes continue for years or become more abnormal.
Genetic risk factors
Many people worry about whether vulva squamous cell carcinoma runs in families. Most cases are not strongly inherited. Instead, they usually arise from DNA changes that happen over time in cells of the vulva, and different tumor subtypes can show different gene patterns. Carrying a genetic change doesn’t guarantee the condition will appear. When people ask about genetic risk factors for vulva squamous cell carcinoma, the clearest inherited links are rare DNA-repair conditions rather than common family traits.
Inherited risk: Most people with vulva squamous cell carcinoma did not inherit a single high-risk cancer gene from a parent. A family history alone is not a strong, well-established cause, although rare inherited conditions can sometimes explain clustering in a family.
Fanconi anemia: Fanconi anemia is a rare inherited condition that makes it harder for cells to repair damaged DNA. People living with it have a higher risk of squamous cell cancers, including cancers of the vulva, often at a younger age.
Xeroderma pigmentosum: Xeroderma pigmentosum is another rare inherited DNA-repair disorder. It is best known for greatly increasing skin cancer risk, and it can also raise the chance of squamous cell cancers in areas such as the vulva.
TP53 changes: Changes in the TP53 gene are common in many vulva squamous cell carcinoma tumors, especially in the non-HPV pathway. These changes usually happen only in the tumor cells and are not passed down through families.
PIK3CA and HRAS: Some tumors carry changes in genes such as PIK3CA or HRAS, which can drive cells to keep growing when they should stop. These are acquired tumor changes rather than inherited risk factors, and not every vulva squamous cell carcinoma has them.
Lifestyle risk factors
Lifestyle risk factors for vulva squamous cell carcinoma are mostly linked to behaviors that increase the chance of persistent human papillomavirus infection or make precancerous changes harder to catch early. Smoking is the clearest modifiable factor. Sexual practices that raise HPV exposure also matter, while diet and exercise do not appear to be major direct drivers of this cancer.
Cigarette smoking raises the risk of vulvar precancer and vulva squamous cell carcinoma, especially when HPV is present. It can weaken local immune defenses and make it harder for the body to clear HPV-related cell changes.
Having multiple sexual partners or unprotected sex can increase exposure to high-risk HPV types that are linked to many vulvar squamous cancers. Reducing HPV exposure through safer sex practices may lower this risk over time.
Skipping HPV vaccination is a preventable behavior that leaves some people at higher risk of HPV infections that can lead to vulvar precancer and cancer. Vaccination does not treat existing disease, but it can reduce future HPV-related risk.
Ignoring persistent vulvar itching, pain, skin color change, or sores can delay diagnosis of precancerous lesions or early cancer. Seeking medical evaluation sooner may allow treatment before more serious disease develops.
Risk prevention
Vulva squamous cell carcinoma, a common type of vulvar cancer, cannot always be prevented, but some steps can lower risk. Prevention matters most around avoiding long-term irritation and infection, treating precancerous changes early, and keeping up with routine gynecologic care. Prevention is about lowering risk, not eliminating it completely.
The HPV vaccine can lower the risk of the virus types linked to many cases of vulva squamous cell carcinoma. It works best before exposure to HPV, but some adults may still benefit depending on age and health history.
Using condoms and limiting exposure to sexually transmitted infections may help reduce HPV spread, which can lower the risk of vulva squamous cell carcinoma. Regular sexual health care also helps find infections that need treatment.
Smoking makes it harder for the body to clear HPV and increases the chance of cell changes that can lead to vulva squamous cell carcinoma. Quitting can lower risk over time and supports healing if treatment is ever needed.
Pelvic and vulvar exams can help find early skin changes before they become cancer. This is especially important if you have persistent itching, burning, skin color changes, or other early symptoms of vulva squamous cell carcinoma.
Can you prevent Vulva squamous cell carcinoma?
You cannot fully prevent vulvar squamous cell carcinoma, but some cases may be less likely with a few proven steps. The clearest ways to lower risk are getting the HPV vaccine, not smoking, and getting checked if you have lasting vulvar itching, burning, skin thickening, color changes, or sores that do not heal, since some early cell changes can be treated before they turn into cancer. Regular follow-up is especially important for people living with long-term vulvar skin conditions or past HPV-related changes.
Transmission
Vulva squamous cell carcinoma is not contagious, so it cannot be passed from one person to another through sex, kissing, shared toilets, towels, or everyday contact. If you are wondering whether vulva squamous cell carcinoma spreads between people, the answer is no.
Some cases are linked to a long-lasting infection with high-risk human papillomavirus, or HPV, and HPV itself can spread through intimate skin-to-skin sexual contact. Even then, most people who get HPV do not develop vulva squamous cell carcinoma, and some vulva squamous cell carcinoma is not related to HPV at all.
When to test your genes
For vulvar squamous cell carcinoma, inherited gene testing is not routine because most cases are not driven by a known family cancer syndrome. It may be worth discussing if you have a strong family history of cancers such as colon, uterine, ovarian, or breast cancer, or if cancer appears unusually early. In advanced or recurrent disease, tumor gene testing can sometimes help guide treatment.
Diagnosis
Vulva squamous cell carcinoma is usually diagnosed after symptoms or skin changes on the vulva lead to an exam. You might notice itching that does not go away, a sore that keeps coming back, pain, burning, bleeding, or a lump that feels different from the surrounding skin. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of vulva squamous cell carcinoma is confirmed by testing a small sample of tissue, not by symptoms alone.
A doctor examines the vulva closely and checks the surrounding skin for sores, thickened areas, color changes, or a visible growth. They may also feel the groin area to see if nearby lymph nodes are enlarged.
A small piece of abnormal tissue is removed and sent to a lab for testing under a microscope. This is the key step in how vulva squamous cell carcinoma is diagnosed because it confirms whether cancer cells are present.
A pathologist studies the biopsy to confirm the cancer type and look at how deeply it has grown into the tissue. These details help guide staging and treatment planning.
Doctors may also examine the vagina and cervix because related cell changes can happen in nearby areas. In some cases, small samples are taken there as well if anything looks suspicious.
How is Vulva squamous cell carcinoma diagnosed?
Doctors usually diagnose vulvar squamous cell carcinoma, a cancer of the outer female genitals, by first doing a careful exam of the area and asking about symptoms such as a sore, lump, itching, pain, or skin changes that do not go away. The diagnosis is confirmed with a biopsy, which means taking a small piece of tissue and checking it under a microscope for cancer cells. If cancer is found, imaging scans such as MRI, CT, or PET and sometimes checks of nearby groin lymph nodes may be used to see whether it has spread; genetic testing is not usually needed to make the diagnosis.
Stages of Vulva squamous cell carcinoma
Vulva squamous cell carcinoma is usually grouped into stages based on how large the cancer is and how far it has spread. This helps doctors estimate how advanced it is and choose treatment. Early and accurate diagnosis helps you plan ahead with confidence.
Stage I
The cancer is only in the vulva or the nearby skin area called the perineum. This is often the stage linked with early symptoms of vulva squamous cell carcinoma, such as itching, soreness, burning, or a lump that does not go away.
Stage II
The cancer has grown into nearby structures such as the lower part of the urethra, the lower vagina, or the anus. It has not spread to the lymph nodes.
Stage III
The cancer may be any size and has spread to nearby lymph nodes in the groin. For many, this can mean a higher chance that treatment will include more than one approach, such as surgery with radiation or chemotherapy.
Stage IV
The cancer has spread more widely into nearby organs like the upper urethra, bladder lining, rectum, or pelvic bone, or to distant parts of the body. This is the most advanced stage and usually needs specialist care tailored to the person's overall health and symptoms.
Outlook and prognosis
Outlook in vulva squamous cell carcinoma depends mainly on stage at diagnosis, lymph node involvement, tumor size, and whether the cancer can be completely removed. When found early and confined to the vulva, prognosis is often favorable, with high 5-year survival rates, whereas spread to inguinal or pelvic lymph nodes markedly worsens outcomes. Local recurrences can occur even after apparently successful treatment, so long-term follow-up is important. Advanced, recurrent, or metastatic disease is associated with lower survival and may require multimodal treatment, including surgery, radiation, and systemic therapy. Mortality is highest in people with node-positive or distant metastatic disease, while older age, significant comorbidities, and delayed diagnosis can also adversely affect survival.
Long-term effects
For many people, the long-term effects of vulva squamous cell carcinoma are linked not only to the cancer itself, but also to surgery, radiation, or other treatment. Day to day, this can mean changes in comfort, movement, urination, bowel habits, sexual health, and emotional well-being. Long-term effects vary widely, and they often depend on the tumor stage, where it was located, and how much treatment was needed. Thinking about the long-term effects helps set realistic expectations for recovery and follow-up care.
Treatment can leave lasting tenderness, numbness, tightness, or scar-related discomfort in the vulvar area. Some may find that sitting for long periods, walking, or wearing tight clothing becomes uncomfortable.
Many living with vulva squamous cell carcinoma notice pain with sex, reduced sensation, dryness, or changes in body confidence after treatment. These effects can last for months or longer, especially after more extensive surgery or radiation.
If lymph nodes are removed or treated with radiation, fluid can build up in the legs or genital area. This swelling, called lymphedema, may become a long-term problem and can make walking or daily activities harder.
Radiation near the pelvis can sometimes lead to ongoing bladder urgency, burning, leakage, diarrhea, or bowel irritation. Some effects may be mild, while others can be more disruptive over time.
How is it to live with Vulva squamous cell carcinoma?
Living with vulvar squamous cell carcinoma can affect some of the most private parts of daily life, from sitting, walking, and wearing certain clothes to urination, sexual intimacy, and sleep, especially when there is pain, itching, burning, or soreness. Many people living with this cancer also carry an emotional weight that others cannot see, including worry about treatment, body image, relationships, and the fear that symptoms in such an intimate area may be misunderstood or hard to talk about. For partners, family, and close friends, this can mean stepping into caregiving roles, helping with appointments and recovery, and learning how to offer support around very personal physical and emotional changes. With good medical care, clear communication, and practical support, many people find ways to protect comfort, dignity, and connection during treatment and recovery.
Treatment and drugs
Treatment for vulva squamous cell carcinoma often depends on the size of the cancer, where it is on the vulva, whether it has spread, and your overall health. Surgery is the main treatment for many people with vulva squamous cell carcinoma, and it may range from removing a small area to a larger operation, sometimes along with nearby lymph nodes to check for spread. Radiation therapy, chemotherapy, or both may be used before surgery to shrink the cancer, after surgery to lower the chance of it coming back, or instead of surgery when an operation is not the best option. Doctors sometimes recommend a combination of lifestyle changes and drugs, and for some people this also includes medicines that help with pain, skin irritation, or side effects during treatment. Finding the right therapy can take some time, but regular follow-up is a key part of care because vulva squamous cell carcinoma can come back and early treatment of any new changes often helps.
Can you cure Vulva squamous cell carcinoma?
Yes, this type of vulvar cancer can sometimes be cured, especially if it is found early and treated quickly. Treatment often involves surgery, and some people also need radiation or chemotherapy to lower the chance of the cancer coming back. If the cancer is more advanced or has spread, treatment may not cure it, but it can still help shrink the cancer, slow it down, and ease symptoms.
Non-drug treatment
Treatment often affects comfort, movement, bladder and bowel habits, and intimacy, so care is usually planned around both cancer control and day-to-day recovery. For many people with Vulva squamous cell carcinoma, the main non-drug treatments are surgery and radiation, with added support to help healing and quality of life. Managing this condition often means combining cancer treatment with practical therapies such as wound care, pelvic floor support, and counseling. The best plan depends on the tumor size, whether nearby lymph nodes are involved, and your overall health.
Surgery is the main non-drug treatment for many people with vulvar squamous cell carcinoma. The goal is to remove the cancer while preserving as much healthy tissue as possible, which can help with healing, walking, and sexual function. Depending on the size and place of the tumor, this may range from a smaller local operation to a more extensive procedure.
Surgery may also check or remove groin lymph nodes because vulvar cancer can spread there first. Some people have a sentinel node procedure, which targets the first likely draining node, while others need more nodes removed. This part of treatment for vulvar squamous cell carcinoma helps guide next steps and estimate the risk of spread.
Radiation uses carefully aimed high-energy beams to destroy cancer cells without an operation. It may be used instead of surgery in selected cases, after surgery if there is a higher risk of cancer returning, or to ease symptoms from more advanced disease. Skin irritation, soreness, and fatigue are common during treatment, but the care team can help manage them.
When a larger area must be removed, reconstructive surgery may help close the wound and improve healing. This can also support comfort, body image, and function after treatment. Not everyone needs reconstruction, and the approach depends on how much tissue is removed.
Your genes may have an impact on how drugs work for you
For people living with vulvar squamous cell carcinoma, inherited differences in their genes can sometimes affect how the body handles certain medicines, including some cancer treatments and pain drugs. This can mean one person gets good pain relief or treatment benefit, while another may have less effect or more side effects, such as severe nausea, unusual tiredness, or nerve pain. Even so, gene-based drug testing is not a routine part of care for most people with this cancer, and treatment is usually guided more by the stage of the cancer, the person’s overall health, and how they respond once treatment starts.
Pharmacological treatments
Drug treatment for vulva squamous cell carcinoma depends a lot on the stage and whether treatment is aimed at shrinking the cancer, helping radiation work better, or treating cancer that has spread or come back. Surgery is often the main treatment, but medicines may be part of care before, during, or after other treatments. Some medicines work quickly, while others are used in more advanced disease, and not everyone with vulva squamous cell carcinoma will need the same drugs.
Cisplatin is one of the most commonly used drugs for vulva squamous cell carcinoma, often given during radiation to help the radiation work better. It may also be used as part of treatment when the cancer is locally advanced and surgery would be difficult at first.
Fluorouracil, often called 5-FU, and mitomycin are chemotherapy drugs sometimes used with radiation in selected cases. They are usually considered when doctors want to intensify treatment for vulva squamous cell carcinoma without relying on surgery alone.
Carboplatin and paclitaxel are commonly used together for recurrent, metastatic, or unresectable vulva squamous cell carcinoma. For many, this can mean treatment aimed at slowing growth, easing symptoms, and improving day-to-day function rather than curing the cancer.
Pembrolizumab is an immunotherapy drug that may be used for some advanced vulva squamous cell carcinoma, especially when the tumor has certain biomarkers such as PD-L1 positivity, MSI-H, or dMMR. If one option is not effective, second-line or alternative drugs may be offered, especially in advanced or relapsed disease.
Genetic influences
When someone is diagnosed with vulva squamous cell carcinoma, a common worry is whether close relatives are also at risk. It’s natural to ask whether family history plays a role. In most cases, vulva squamous cell carcinoma is not caused by one inherited gene; it usually develops after cells in the vulva build up DNA changes over time, often alongside long-lasting high-risk HPV infection or a chronic vulvar skin condition such as lichen sclerosus. Some tumors carry changes in genes that normally keep cell growth under control, but these changes are usually limited to the cancer itself and are not passed from parent to child. So if you are wondering whether vulva squamous cell carcinoma runs in families, the answer is usually no, although a strong pattern of several cancers in one family can sometimes point to a rare inherited syndrome. If cancer happens at an unusually young age or there is a striking family history, the care team may suggest genetic counseling to decide whether inherited testing would be useful.
Is Vulva squamous cell carcinoma genetic?
Genetics can matter in vulva squamous cell carcinoma, but inherited causes are uncommon. Most cases are linked more to acquired DNA changes over time, often alongside HPV infection or chronic skin conditions, than to a strong family pattern.
Having a genetic risk is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most of them do not directly affect health and are simply part of normal human diversity. With many genes, carrying a variant linked to a condition means there may be an association rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well-understood variant in a particular gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with vulva squamous cell carcinoma, treatment is not always one-size-fits-all. In advanced, recurrent, or metastatic vulva squamous cell carcinoma, doctors may test the tumor for certain markers to see whether immunotherapy or another drug is more likely to help, while many treatment decisions still depend on the cancer’s size, location, spread, and your overall health. Not every difference in response is genetic, but inherited gene changes can sometimes affect how the body handles cancer medicines, including whether side effects are more likely or unusually severe. This matters most with some chemotherapy drugs, where a genetic test may occasionally be considered before treatment or after an unexpected reaction. Even with the same gene pattern, people can still respond differently, so genetic results are usually just one part of planning care. For many, this can mean that the best treatment for vulva squamous cell carcinoma is chosen by combining tumor testing, medical history, and how the cancer has behaved so far.
Interactions with other conditions
People living with vulva squamous cell carcinoma may also be dealing with other health problems that affect symptoms, treatment choices, and recovery. This cancer is often seen alongside long-term skin conditions of the vulva, especially lichen sclerosus, which can cause itching, soreness, and skin changes that make early symptoms of vulva squamous cell carcinoma easier to miss or harder to sort out. It can also occur in people who have cervical, vaginal, or anal precancers or cancers linked to human papillomavirus, because these areas can be affected by some of the same risk factors. Doctors call it a comorbidity when two conditions occur together. For many, this can mean treatment planning needs extra care if they also have diabetes, heart disease, poor circulation, or immune system problems, since these can slow wound healing or raise the risk of infection after surgery or radiation. If swollen groin lymph nodes, pain, or skin breakdown are present, infections or inflammatory conditions may add to discomfort, so it is important for the medical team to look at the full picture rather than assume every symptom is caused by vulva squamous cell carcinoma alone.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulva squamous cell carcinoma?
Several noncancer problems can look or feel similar to vulva squamous cell carcinoma, including a long-term skin condition called lichen sclerosus that causes thin, itchy skin, eczema or other irritation, yeast or herpes infections, genital warts, and cysts or blocked glands near the vaginal opening. Precancer changes in the vulva can also cause itching, pain, color changes, a lump, or a sore that does not heal, so symptoms like these should be checked by a doctor.
History
Long before modern cancer testing, doctors described sores, lumps, or persistent skin changes on the vulva that did not heal and sometimes slowly grew worse over time. These older reports did not always separate vulva squamous cell carcinoma from other vulvar conditions, because the tools to examine tissue closely were limited. Many living with this cancer in the past were likely diagnosed late, after pain, bleeding, irritation, or trouble sitting and walking had already started to affect daily life.
In recent decades, awareness has grown as doctors learned to distinguish vulva squamous cell carcinoma from other cancers and from noncancerous skin disorders of the vulva. Once considered rare, now recognized as an important form of vulvar cancer, it became easier to identify when microscopic tissue testing became routine. This helped doctors see that some cases develop from long-standing skin changes, while others may be linked to infections or irritation over many years. As medical science evolved, researchers also saw that vulva squamous cell carcinoma is not the same in every person, which helped explain why symptoms, age at diagnosis, and treatment needs can vary.
The history of treatment has also changed a great deal. Earlier care often relied on large, disfiguring operations, sometimes with major effects on urination, sexual function, comfort, and body image. Over time, surgery became more targeted, and doctors added better imaging, careful lymph node assessment, and radiation or drug treatment when needed. For many, this has meant a better chance of controlling the cancer while preserving more normal function.
This growing knowledge has also improved prevention and earlier diagnosis. Doctors now better recognize warning signs such as a vulvar sore that does not heal, persistent itching, skin thickening, or a new lump, which can lead to testing sooner. Knowing the condition’s history helps explain why attention to early symptoms of vulva squamous cell carcinoma matters: the earlier it is found, the more treatment options people often have, and the better the outlook can be.